Showing 1,021 - 1,040 results of 41,035 for search '(( 5 ((mean decrease) OR (fold decrease)) ) OR ( 100 ((nn decrease) OR (a decrease)) ))', query time: 0.90s Refine Results
  1. 1021

    HRMECs treated with 3-Deazaneplanocin A (DZNep) chemical inhibitor demonstrated increased miR-200b and decreased VEGF expression. by Michael Anthony Ruiz (726055)

    Published 2015
    “…[NG = 5mM D-glucose, HG = 25mM D-glucose, NG+DMSO = 5mM D-glucose + 0.05% DMSO, HG+DMSO = 25mM D-glucose + 0.05% DMSO, NG+DZNEP = 5mM D-glucose + 5μM DZNep, HG+DZNEP = 25mM + 5μM DZNep; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to β-actin for VEGF and U6 for miR-200b, expressed as a fold change of NG].…”
  2. 1022

    Vasopressin decreased the population fEPSP evoked by stimulation of LIII entorhinal fibers (EC LIII) and recorded in the CA2 dendritic field. by Magda Chafai (295116)

    Published 2013
    “…AVP (1 min) transiently decreased the LTP-potentiated fEPSP. B) Average graphs (n = 8; values expressed as % of the mean of the responses recorded during 5 min before AVP application) demonstrating that AVP (100 nM; 1 min) transiently and significantly decreased the amplitude of both S1 and S2 fEPSPs without affecting the paired-pulse facilitation (calculated as the ratio S2/S1). …”
  3. 1023

    Table 5_Road transportation is associated with decreased intestinal motility in horses.docx by Sharanne L. Raidal (3097719)

    Published 2025
    “…Signalment and past travel history were not predictive of intestinal motility, but horses with unknown or no prior travel history (mean 12.8, 95%CI 8.2-17.4 nmol/L) had higher cortisol concentrations prior to departure than horses known to have travelled previously (7.9, 5.8−9.9 nmol/L, p = 0.023).…”
  4. 1024
  5. 1025
  6. 1026
  7. 1027
  8. 1028
  9. 1029
  10. 1030
  11. 1031
  12. 1032
  13. 1033
  14. 1034
  15. 1035

    Gross Cystic Disease Fluid Protein 15 in Stratum Corneum Is a Potential Marker of Decreased Eccrine Sweating for Atopic Dermatitis by Koji Kamiya (731109)

    Published 2015
    “…To identify GCDFP15-producing cells, double immunofluorescence staining for GCDFP15 and S100 protein was performed in frozen sections. To address the mechanism underlying the decreased eccrine sweating in AD patients, we examined the expression of cholinergic receptor M3 (CHRM3), a receptor for acetylcholine-induced sweating, in eccrine sweat glands. …”
  16. 1036
  17. 1037
  18. 1038
  19. 1039
  20. 1040